Asarina Pharma AB

COO:  Karin Ekbergasarina pharma


Description: Based on science from Umeå university, the focus of Asarina Pharma is development of pharmaceuticals to treat unwanted effects of GABA-steroids that acts on the central nervous system. Asarina Pharma develops a new treatment for Premenstrual Dysphoric Disorder, which is the most severe form of PMS and has now one of its compounds in clinical testing in patients.

Share Button